{"id":89848,"date":"2026-01-24T12:46:37","date_gmt":"2026-01-24T12:46:37","guid":{"rendered":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/24\/lupin-earns-top-cdp-a-rating-for-efforts-in-combating-climate-change-and-conserving-water\/"},"modified":"2026-01-24T12:46:37","modified_gmt":"2026-01-24T12:46:37","slug":"lupin-earns-top-cdp-a-rating-for-efforts-in-combating-climate-change-and-conserving-water","status":"publish","type":"post","link":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/24\/lupin-earns-top-cdp-a-rating-for-efforts-in-combating-climate-change-and-conserving-water\/","title":{"rendered":"Lupin Earns Top CDP A Rating for Efforts in Combating Climate Change and Conserving Water"},"content":{"rendered":"<p>Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest &#8216;A&#8217; leadership rating from the Climate Disclosure Project (CDP) for its exceptional performance in Climate Change and Water Security. This recognition is a testament to Lupin&#8217;s commitment to sustainability and transparency, placing the company among the world&#8217;s leading organizations that prioritize environmental stewardship.<\/p>\n<p>Lupin&#8217;s double &#8216;A&#8217; rating in Climate and Water demonstrates its proactive approach to mitigating climate risks, reducing carbon emissions, and ensuring responsible water management throughout its operations. This achievement represents a significant improvement from the company&#8217;s previous ratings, with a substantial enhancement from &#8216;A-&#8216; in 2024 and &#8216;B&#8217; in 2023 for climate, and &#8216;C&#8217; for water. This progress reflects Lupin&#8217;s dedication to continuous improvement and its efforts to establish new sustainability standards.<\/p>\n<p>The company&#8217;s Executive Director, Ramesh Swaminathan, attributed this achievement to Lupin&#8217;s innovative approaches, collaborative efforts, and transparency. He emphasized that the CDP&#8217;s framework has helped shape and accelerate the company&#8217;s climate initiatives, driving ongoing progress. Lupin&#8217;s commitment to sustainability is also reflected in its S&#038;P Global ESG score of 91 in 2025, which is a best-in-class global achievement. This score positions Lupin among a select group of companies worldwide that have surpassed the 90-point threshold, demonstrating its exceptional performance in environmental, social, and governance (ESG) aspects.<\/p>\n<p>Lupin&#8217;s achievement is a significant milestone in the pharmaceutical industry, highlighting the company&#8217;s dedication to reducing its environmental impact while generating lasting value for its communities and the planet. By prioritizing sustainability and transparency, Lupin is setting a high standard for the industry and demonstrating its commitment to creating a better future for all stakeholders. Overall, Lupin&#8217;s double &#8216;A&#8217; rating from CDP and its exceptional ESG score are a testament to the company&#8217;s leadership in sustainability and its efforts to make a positive impact on the environment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest &#8216;A&#8217; leadership rating from the Climate Disclosure Project (CDP) for its exceptional performance in Climate Change and Water Security. This recognition is a testament to Lupin&#8217;s commitment to sustainability and transparency, placing the company among the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[20,2],"tags":[],"class_list":["post-89848","post","type-post","status-publish","format-standard","hentry","category-lupin","category-pharma"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89870,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/27\/lupin-achieves-top-esg-rating-from-cdp-for-its-efforts-in-addressing-climate-change-and-water-security\/","url_meta":{"origin":89848,"position":0},"title":"Lupin achieves top ESG rating from CDP for its efforts in addressing climate change and water security.","author":"Team Small News","date":"January 27, 2026","format":false,"excerpt":"Lupin, a global pharmaceutical leader, has been recognized for its exceptional sustainability efforts, receiving the highest \"A\" leadership rating from the Climate Disclosure Project (CDP) for both Climate Change and Water Security. This prestigious recognition solidifies Lupin's position among the world's most sustainable and transparent companies. The double \"A\" rating\u2026","rel":"","context":"In &quot;Lupin&quot;","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89855,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/25\/lupin-achieves-prestigious-cdp-double-a-rating-for-excellence-in-climate-change-mitigation-and-water-stewardship\/","url_meta":{"origin":89848,"position":1},"title":"Lupin Achieves Prestigious CDP Double &#8216;A&#8217; Rating for Excellence in Climate Change Mitigation and Water Stewardship","author":"Team Small News","date":"January 25, 2026","format":false,"excerpt":"Lupin, a global pharmaceutical company, has achieved a significant milestone in its sustainability journey by earning a double 'A' rating from CDP (formerly known as the Carbon Disclosure Project) for its leadership in climate action and water security. This prestigious rating recognizes Lupin's efforts to reduce its environmental impact and\u2026","rel":"","context":"In &quot;Lupin&quot;","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89844,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/23\/lupin-achieves-top-esg-score-from-cdp-for-efforts-in-combating-climate-change-and-ensuring-water-security-reported-by-chennai-patrika\/","url_meta":{"origin":89848,"position":2},"title":"Lupin Achieves Top ESG Score from CDP for Efforts in Combating Climate Change and Ensuring Water Security &#8211; Reported by Chennai Patrika.","author":"Team Small News","date":"January 23, 2026","format":false,"excerpt":"Lupin Limited, a global pharmaceutical major, has achieved a significant milestone in its sustainability efforts by receiving the highest 'A' leadership rating from the Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change and Water Security. This recognition solidifies Lupin's position as a global leader in championing sustainability\u2026","rel":"","context":"In &quot;Lupin&quot;","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89790,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/12\/lupin-partners-with-gan-lee-to-bring-fortnightly-glp-1-treatment-to-india-through-exclusive-licensing-deal\/","url_meta":{"origin":89848,"position":3},"title":"Lupin partners with Gan &#038; Lee to bring fortnightly GLP-1 treatment to India through exclusive licensing deal.","author":"Team Small News","date":"January 12, 2026","format":false,"excerpt":"Lupin Limited, a global pharmaceutical company, has entered into an exclusive agreement with Gan&Lee Pharmaceuticals of China to commercialize Bofanglutide, a novel GLP-1 receptor agonist, in India. Bofanglutide is a fortnightly treatment for type 2 diabetes and weight management in overweight and obese adults, offering a reduced injection frequency compared\u2026","rel":"","context":"In &quot;Lupin&quot;","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89792,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/13\/piramal-pharma-enhances-its-global-sustainability-rating-in-recent-corporate-assessment\/","url_meta":{"origin":89848,"position":4},"title":"Piramal Pharma Enhances Its Global Sustainability Rating in Recent Corporate Assessment.","author":"Team Small News","date":"January 13, 2026","format":false,"excerpt":"Piramal Pharma, a leading global pharmaceutical company, has achieved a significant improvement in its score on the Global Corporate Sustainability Assessment (CSA) conducted by S&P Global. The CSA is a widely recognized benchmark for assessing a company's sustainability performance, evaluating factors such as environmental, social, and governance (ESG) practices. In\u2026","rel":"","context":"In &quot;Pharma&quot;","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":89755,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/05\/polypeptide-forms-partnership-with-lupin-speciality-chemicals-magazine\/","url_meta":{"origin":89848,"position":5},"title":"PolyPeptide forms partnership with Lupin | Speciality Chemicals Magazine","author":"Team Small News","date":"January 5, 2026","format":false,"excerpt":"PolyPeptide, a leading manufacturer of peptides, has formed a strategic alliance with Lupin Manufacturing Solutions. The partnership aims to establish a framework for long-term cooperation, focusing on integrated procurement and supply planning for select raw materials. This alliance will enable PolyPeptide to diversify its sourcing options for key materials, including\u2026","rel":"","context":"In &quot;Lupin&quot;","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89848"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89848\/revisions"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}